Fluoxetine Impurity 16 | CAS 74681-55-3 - Request Quote
Fluoxetine Impurity 16
| SZ CAT No: | SZ-F001036 |
| CAS No | 74681-55-3 |
| Mol.F. | C17H21NO |
| Mol.Wt. | 255.4 |
| Inv. Status | In Stock |
| Rel. CAS No | 660414-53-9 (HCl salt) |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Fluoxetine Impurity 16 is chemically 3-(Benzyl(methyl)amino)-1-phenylpropan-1-ol. Fluoxetine Impurity 16 is supplied with detailed characterization data compliant with regulatory guideline. Fluoxetine Impurity 16 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Fluoxetine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 74681-55-3
Purchase 74681-55-3
Order 74681-55-3
Enquire 74681-55-3
price of 74681-55-3
74681-55-3 Supplier
74681-55-3 Manufacturer
74681-55-3 Exporter
buy high quality Fluoxetine Impurity 16
Purchase Fluoxetine Impurity 16
Fluoxetine Impurity 16 suppliers
Fluoxetine Impurity 16 manufacturers
Fluoxetine Impurity 16 price
Order Fluoxetine Impurity 16
Enquire Fluoxetine Impurity 16
Fluoxetine Impurity 16 cost
Fluoxetine Impurity 16 Supplier
Fluoxetine Impurity 16 Distributor
Fluoxetine Impurity 16 for Method Validation
Fluoxetine Reference Standard
Fluoxetine Impurity 16 for ANDA Filing
Fluoxetine Impurity 16 for Forced Degradation Studies
Fluoxetine Impurity 16 Identification Standards
Fluoxetine Impurity 16 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


